Holen Sie sich die Stockscreener-App
3.99
3.16%
-0.13
Schlusskurs vom Vortag:
$4.12
Offen:
$4.08
24-Stunden-Volumen:
1.29M
Relative Volume:
0.70
Marktkapitalisierung:
$687.92M
Einnahmen:
$25.55M
Nettoeinkommen (Verlust:
$-341.97M
KGV:
-1.425
EPS:
-2.8
Netto-Cashflow:
$-304.44M
1W Leistung:
-3.16%
1M Leistung:
+19.10%
6M Leistung:
+9.02%
1J Leistung:
-47.64%
1-Tages-Spanne:
$3.97
$4.087
1-Wochen-Bereich:
$3.865
$4.202
52-Wochen-Spanne:
$1.775
$8.315
Relay Therapeutics Inc Stock (RLAY) Company Profile
Firmenname
Relay Therapeutics Inc
Sektor
Branche
Telefon
617-370-8837
Adresse
60 HAMPSHIRE STREET, CAMBRIDGE
Vergleichen Sie RLAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
3.99 | 699.99M | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | Guggenheim | Buy |
| 2025-04-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-10 | Fortgesetzt | Goldman | Buy |
| 2024-09-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-04-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Eingeleitet | Raymond James | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-09-30 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-02 | Eingeleitet | Stifel | Buy |
| 2022-06-06 | Eingeleitet | Jefferies | Underperform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-07-21 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-10 | Eingeleitet | Cowen | Outperform |
| 2020-08-10 | Eingeleitet | Goldman | Buy |
| 2020-08-10 | Eingeleitet | Guggenheim | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
Invesco Ltd. Grows Stake in Relay Therapeutics, Inc. $RLAY - MarketBeat
Trexquant Investment LP Reduces Stock Position in Relay Therapeutics, Inc. $RLAY - MarketBeat
OMERS ADMINISTRATION Corp Makes New Investment in Relay Therapeutics, Inc. $RLAY - MarketBeat
Parkman Healthcare Partners LLC Has $493,000 Position in Relay Therapeutics, Inc. $RLAY - MarketBeat
Relay Therapeutics’ Promising Phase 2 Study on RLY-2608: A Potential Game-Changer in Targeted Therapy - MSN
Relay Therapeutics, Inc. $RLAY Shares Sold by Walleye Capital LLC - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Now Covered by Guggenheim - MarketBeat
Fibonacci Retracement Aligns with Support in Relay Therapeutics Inc.July 2025 Trade Ideas & Real-Time Price Movement Reports - beatles.ru
Relay Therapeutics (NASDAQ:RLAY) Trading Up 7.6%Should You Buy? - MarketBeat
Guggenheim Gives Buy Rating to Relay Therapeutics (RLAY) - Yahoo Finance
Nuveen LLC Invests $839,000 in Relay Therapeutics, Inc. $RLAY - MarketBeat
Will a bounce in Relay Therapeutics Inc. offer an exitMarket Volume Summary & Short-Term Trading Opportunity Alerts - Newser
What’s the profit margin of Relay Therapeutics Inc.July 2025 Macro Moves & Risk Controlled Swing Alerts - خودرو بانک
Is Relay Therapeutics Inc. a defensive stockEarnings Growth Summary & Long-Term Capital Growth Strategies - خودرو بانک
Why Relay Therapeutics Stock Rocketed Nearly 15% Higher This Week - sharewise.com
Relay Therapeutics (RLAY) Stock Rises on Bullish Analyst Note - GuruFocus
Can Relay Therapeutics Inc. expand its profit margins2025 Winners & Losers & Weekly Top Performers Watchlists - خودرو بانک
Tools to assess Relay Therapeutics Inc.’s risk profileEarnings Performance Report & Reliable Breakout Forecasts - Newser
Pattern recognition hints at Relay Therapeutics Inc. upside2025 Key Highlights & Reliable Price Breakout Signals - Newser
What MACD signals say about Relay Therapeutics Inc.Weekly Profit Analysis & Breakout Confirmation Alerts - Newser
Real time breakdown of Relay Therapeutics Inc. stock performance2025 Volume Leaders & Verified Momentum Stock Watchlist - Newser
Predicting Relay Therapeutics Inc. trend using moving averagesMarket Performance Recap & Weekly Stock Performance Updates - Newser
Will Relay Therapeutics Inc. see short term momentumTrade Risk Summary & Long-Term Safe Investment Ideas - Newser
Relay Therapeutics (RLAY) Receives a Buy from Guggenheim - The Globe and Mail
Will Relay Therapeutics Inc. stock hit new highs in YEAR2025 Technical Patterns & AI Forecasted Entry and Exit Points - خودرو بانک
Will Relay Therapeutics Inc. continue its uptrendGlobal Markets & Technical Buy Zone Confirmations - Newser
News impact scoring models applied to Relay Therapeutics Inc.Market Growth Report & Detailed Earnings Play Alerts - Newser
Is Relay Therapeutics Inc. a momentum stock2025 Buyback Activity & AI Powered Market Entry Ideas - خودرو بانک
Guggenheim initiates Relay Therapeutics stock with Buy rating, cites strong oncology pipeline - Investing.com Canada
Momentum divergence signals in Relay Therapeutics Inc. chartWeekly Stock Recap & Consistent Growth Equity Picks - Newser
How moving averages guide Relay Therapeutics Inc. tradingWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
What does recent volatility data suggest for Relay Therapeutics Inc.2025 Market Overview & Precise Swing Trade Entry Alerts - Newser
Can Relay Therapeutics Inc. hit a new high this monthDip Buying & Risk Controlled Stock Alerts - Newser
Relay Therapeutics Inc. stock daily chart insightsGap Up & Safe Entry Trade Signal Reports - Newser
What candlestick patterns are forming on Relay Therapeutics Inc.CPI Data & Weekly Breakout Watchlists - Newser
Published on: 2025-09-03 06:45:04 - Newser
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary - GlobeNewswire Inc.
Is Relay Therapeutics Inc. still worth holding after the dip2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Heatmap analysis for Relay Therapeutics Inc. and competitorsJuly 2025 Trade Ideas & Daily Risk Controlled Trade Plans - Newser
Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Relay Therapeutics Inc-Aktie (RLAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Jul 28 '25 |
Sale |
3.74 |
1,359 |
5,083 |
393,722 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 29 '25 |
Sale |
3.68 |
18,380 |
67,638 |
335,295 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 28 '25 |
Sale |
3.74 |
1,701 |
6,362 |
353,675 |
| Bergstrom Donald A | President, R&D |
Jul 29 '25 |
Sale |
3.68 |
26,701 |
98,260 |
552,720 |
| Bergstrom Donald A | President, R&D |
Jul 28 '25 |
Sale |
3.74 |
4,069 |
15,218 |
579,421 |
| Adams Brian | Chief Legal Officer |
Jul 29 '25 |
Sale |
3.68 |
18,276 |
67,256 |
371,472 |
| Adams Brian | Chief Legal Officer |
Jul 28 '25 |
Sale |
3.74 |
1,637 |
6,122 |
389,748 |
| Patel Sanjiv | President and CEO |
Jul 09 '25 |
Sale |
3.57 |
61,379 |
219,123 |
765,288 |
| Rahmer Peter | See remarks |
Apr 30 '25 |
Sale |
3.00 |
10,739 |
32,217 |
390,081 |
| Rahmer Peter | See remarks |
Apr 28 '25 |
Sale |
3.17 |
1,364 |
4,324 |
400,820 |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):